Modified Relaxin Polypeptides and Their Uses
AssigneeAmbrx, Inc.
InventorsVadim KRAYNOV, Nick KNUDSEN, Amha HEWET, Kristine DE DIOS, Jason PINKSTAFF, Lorraine SULLIVAN
Life of this patent
Estimating the term…
Abstract
Modified relaxin polypeptides and their uses thereof are provided. Exemplary embodiments provide relaxin polypeptides which include one or more amino acid substitutions with natural or non-naturally encoded amino acids, and/or linkage to a water-soluble polymer, such as polyethylene glycol. Additionally, use of said relaxin polypeptides for treatment of disease, such as heart failure, is also provided.
Claims22
A modified relaxin polypeptide wherein:
- (a) said modified relaxin polypeptide comprises a relaxin A chain polypeptide and a relaxin B chain polypeptide, wherein said relaxin A chain polypeptide has a sequence at least 90% identical to SEO ID NO:
- 4, and said relaxin B chain polypeptide has a sequence at least 90% identical to SEQ ID NO:
- 5 or SEQ ID NO:
- 6, and comprises a non-naturally encoded amino acid which is substituted in said A chain polypeptide at a residue selected from position 1, 2, 5, 13 and 18, or said non-naturally encoded amino acid is substituted in said B chain polypeptide at a residue selected from position 7, 18 and 28;
- and (b) said non-naturally encoded amino acid is linked to a linker or polymer, wherein said non-naturally encoded amino acid comprises a first functional group and the linker or polymer comprises a second functional group, wherein the first functional group and second functional group are not identical and each comprise a carbonyl group, an aminooxy group, a hydrazide group, a hydrazine group, a semicarbazide group, an azide group, or an alkyne group, and the resultant covalent linkage created by the reaction of the first and second functional groups comprises a triazole or an oxime linkage.
2-67. (canceled)
69-119. (canceled)
121-210. (canceled)
212-250. (canceled)
252-259. (canceled)
266-268. (canceled)
Dependencies are inferred from the claim text.